Should an Inhaled Steroid Accompany Each Dose of Beta Agonist for Relief of Asthma Symptoms?

CNMC Ped Pulmonology State of Art 6.7.24.pdf

Learning objectives:

• Identify patients that are likely to benefit from PRN combination products containing an inhaled corticosteroid and fast-acting beta agonist (ICS-FABA).
• Indicate which asthma phenotypes are likely to benefit from the use of a single inhaler for both maintenance and reliever therapy (S.M.A.R.T.)
• Describe the obstacles to prescribing PRN ICS-FABA products for pediatric patients in the USA.